NovaBridge Biosciences (NBP) Net Cash Flow (2019 - 2025)
NovaBridge Biosciences (NBP) reported Net Cash Flow of $142.1 million for Q4 2025, up 664.51% year-over-year from $18.6 million in Q4 2024, and up 1712.41% on a QoQ basis from $7.8 million in Q3 2025.
NovaBridge Biosciences (NBP) has 4 years of Net Cash Flow data on file, last reported at $142.1 million in Q4 2025.
- Quarterly Net Cash Flow rose 664.51% year-over-year to $142.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $149.9 million (up 2456.33% YoY) and the FY2025 annual result came in at $142.1 million, up 279.57% from the prior year.
- Net Cash Flow improved to $142.1 million in Q4 2025 per NBP's latest filing, from $7.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $142.1 million in Q4 2025 and bottomed at -$25.2 million in Q4 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 142.09 Mn |
| Dec 31, 2025 | 142.09 Mn |
| Sep 30, 2025 | 7.84 Mn |
| Sep 30, 2025 | 7.84 Mn |
| Dec 31, 2024 | -25.17 Mn |
| Dec 31, 2024 | -25.17 Mn |
| Sep 30, 2024 | 18.81 Mn |
| Sep 30, 2024 | 18.81 Mn |
| Dec 31, 2020 | 289.03 Mn |
| Dec 31, 2020 | 289.03 Mn |
| Sep 30, 2020 | 205.50 Mn |
| Sep 30, 2020 | 205.50 Mn |
| Dec 31, 2019 | -3.60 Mn |
| Dec 31, 2019 | -3.60 Mn |